Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06550895
Title A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma (MonumenTAL-8)
Acronym MonumenTAL-8
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
University of California San Francisco SUSPENDED San Francisco California 94143 United States Details
University of Iowa Hospital and Clinics RECRUITING Iowa City Iowa 52242 United States Details
Norton Cancer Institute RECRUITING Louisville Kentucky 40207 United States Details
Barbara Ann Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Icahn School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center SUSPENDED New York New York 10065 United States Details
Thomas Jefferson University SUSPENDED Philadelphia Pennsylvania 19107 United States Details
Medical College Of Wisconsin SUSPENDED Milwaukee Wisconsin 53226 United States Details
Royal Prince Alfred Hospital RECRUITING Camperdown 2050 Australia Details
Austin Hospital RECRUITING Heidelberg 3084 Australia Details
Peter MacCallum Cancer Centre RECRUITING Melbourne 3000 Australia Details
The Alfred Hospital RECRUITING Melbourne 3004 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field